Systematic review and meta-analysis on the outcomes after fenestrated-branched endovascular repair in post-dissection thoracoabdominal aortic aneurysms.

J Vasc SurgJun 19, 2026 (epub)
Clinical ResearchVascular Surgery

Mezzetto Luca, Grosso Lorenzo, D'Oria Mario et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and random-effects meta-analysis assessed clinical and target-vessel outcomes after fenestrated or branched endovascular repair for post-dissection thoracoabdominal aortic aneurysms. It included 17 retrospective studies with 912 patients and 3229 target vessels. Technical success was 96.0%; after a mean follow-up of 23.5 months, pooled target-vessel instability was 7.6% and target-vessel reintervention was 6.9%. Outcome heterogeneity prevented direct comparison of fenestrated with branched repair. The authors considered the approach viable, while identifying target-vessel durability, particularly for renal arteries, as an ongoing concern.

Key findings

  • Across 17 retrospective studies, technical success was 96.0% among 912 patients.
  • Pooled major adverse events were 4.6%, and early mortality was 4.1%.
  • After a mean follow-up of 23.5 months, pooled mortality was 12.8%, target-vessel instability 7.6%, and target-vessel reintervention 6.9%.
  • Renal arteries had higher reported target-vessel instability and reintervention rates than visceral arteries; heterogeneity precluded direct comparison of FEVAR and BEVAR.

Why it matters

These pooled results provide an overview of outcomes for a complex aneurysm population treated with fenestrated or branched endovascular repair. High technical success supports its consideration as an endovascular strategy, but target-vessel events and midterm mortality remain relevant outcomes. The reported renal-vessel durability concern and variation in outcome reporting underscore the need for careful follow-up and more consistent evidence.

What to keep in mind

All included studies were retrospective, outcome reporting was heterogeneous, and mean follow-up was 23.5 months. The heterogeneity prevented direct comparison between FEVAR and BEVAR.

Source

Published in J Vasc Surg. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Vascular Surgery

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.